Sort by
Refine Your Search
-
opportunity: · Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive responses to chemotherapies and
-
-seq and next generation long reads sequencing from Oxford Nanopore. · Participate in the development of new computational methods for downstream analysis of genomics data and multiomics
-
career development. For more information about Dr. You’s lab, please visit here. As a successful candidate, you will: Lead independent and collaborative projects investigating the molecular and cellular
-
: · Contribute to the development of CD38 antibody‑drug conjugates (ADCs) and other multiple myeloma targets, including monoclonal antibody (mAb) engineering, ADC conjugation, biophysical characterization (SPR
-
highly motivated postdoctoral fellow to study transcriptional regulation and RNA metabolism in normal development and human diseases, such as neurological disorder, immunology, and cancer. In particular
-
publications and scientific presentations and engage in lab meetings, seminars, and professional development activities. Your qualifications should include: · Candidates must hold an MD or PhD
-
hematopoiesis, leukemogenesis, and tumorigenesis as well as developing new targeted therapies for hematological malignant diseases and cancers. Our research involves experiments with various biochemistry and
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
Institute at City of Hope. You will work on projects related to the molecular mechanisms underlying the aging-related diabetes development using genetically engineered mouse models and multiple omics
-
failure from a developmental perspective. We are interested in the dynamics of beta-cell heterogeneity, islet organization and cell-cell interaction in fetal and neonatal development. The Dhawan lab